Emmanuel Reyes Ramos
Gastroenterology · San Juan, PRNPI 1326332743
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 36.2% of the total. Reporting peaked in 2019 at $1,554 and has fallen 77.0% since, to $357 in 2025.
Across 360 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Ironwood Pharmaceuticals, Inc$958
- Takeda Pharmaceuticals U.S.A., Inc.$390
- Romark Laboratories, LC$298
- Gilead$217
- plus $1K from 18 others
What the payments were for
- Food & beverage$6,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 124 | $2,310 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 97 | $1,104 |
| Ironwood Pharmaceuticals, Inc | 45 | $958 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $390 |
| Romark Laboratories, LC | 10 | $298 |
| Gilead | 15 | $217 |
| Braintree Laboratories, Inc. | 7 | $144 |
| Genentech USA, Inc. | 1 | $143 |
| QOL Medical, LLC | 7 | $134 |
| Intercept Pharmaceuticals, Inc. | 8 | $129 |
| Daiichi Sankyo Inc. | 5 | $92 |
| Ferring Pharmaceuticals Inc. | 5 | $85 |
| Johnson & Johnson | 4 | $84 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $47 |
| Dova Pharmaceuticals | 2 | $37 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Exact Sciences | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,380 in reported general payments places this provider in the 80th percentile of 198 gastroenterology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 67 | $1,843 |
| Sucralfate | 19 | $1,742 |
| Clarithromycin | 19 | $773 |
| Omeprazole | 101 | $671 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 23 | $583 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $410 |
| Fentanyl CitrateFentanyl Citrate/Pf | 111 | $380 |
| Amoxicillin | 17 | $312 |
| Midazolam HclMidazolam Hcl/Pf | 108 | $312 |
| Midazolam Hcl | 95 | $259 |
| Famotidine | 32 | $244 |
| Pantoprazole Sodium | 24 | $202 |
| Sodium Chloride0.9 % Sodium Chloride | 29 | $138 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Juan
- Marcia Cruz CorreaSan Juan$62K
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
- Hector LozanoSan Juan$28K
- Rafael Rodriguez LopezSan Juan$20K
- Alexis Gonzalez RiveraSan Juan$16K
- Sulimar Rodriguez SantiagoSan Juan$11K
- Esther TorresSan Juan$9K
- Yahaira Moreno DenizardSan Juan$9K
- Ricky Jimenez CarloSan Juan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.